The legacy of the blue pill offers a complex case study for investors eyeing pharma. While first sales were explosive, current patent expiry and the rise of cheaper versions have severely impacted earnings. Moreover, https://kaitlynukgd952256.collectblogs.com/85681975/sildenafil-and-the-pharmaceutical-industry-a-precarious-stake